Medical-Grade Wearable Sensors for Clinical Research
Explore our ODM/OEM continuous vital sign monitors tailored for pharmaceutical oncology protocols, clinical site trials, and remote decentralization across Hungary and the European Union.
- Single-Lead Clinical ECG & PPG
- IP68 Waterproof for 24/7 Wear
- Continuous Blood Pressure Trend
- Raw Signal Export (128 Hz)
- Designed for Patient Compliance
- Medical-Grade Micro-Sensors
- Long Battery Life (10+ Days)
- Custom Firmware Options
- Standalone 4G Cellular Telemetry
- Continuous SpO2 & Body Temp
- Integrated SOS & Patient Location
- Senior & Vulnerable Cohort Monitoring
- Ultra-Lightweight Ergonomic Form
- Discrete Dual Electrodes
- High-Precision ECG Waveform
- Ideal for Decentralized Trials
- Zero-Distraction Screenless UI
- Medical-Grade Skin Temp Sensor
- Automated Early Warning Metrics
- GDPR/HIPAA Data Streaming
- 1ATM Dynamic Water Resistance
- Continuous PPG & ECG Telemetry
- SDK/API Direct Integration
- Custom Protocol Firmware
- 15-Day Continuous Wear Operating Cycle
- 3ATM Industrial Waterproof Rating
- Raw PPG & Motion Actigraphy
- Automated Compliance Tracking
- Integrated Patient NFC ID Tagging
- Advanced Pulse Wave Analysis
- Multi-Wave PPG (Green/Red/IR)
- Full Raw Signal Export via API
Transforming Oncology Clinical Trials in Hungary Through Continuous Wearable Telemetry
Modern oncology clinical research demands robust, continuous safety monitoring without inflating patient burden or clinical site friction. Traditional clinical trial protocols rely heavily on episodic in-clinic evaluations, creating significant biophysiological blind spots between patient visits. In targeted cancer therapies, immune-oncology treatments (e.g., CAR-T cell infusions, immune checkpoint inhibitors), and novel cytotoxic regimens, sub-clinical toxicities can escalate rapidly into life-threatening adverse events (AEs).
As a specialized B2B factory and global original device manufacturer (ODM/OEM) supplying the Hungarian pharmaceutical ecosystem, our continuous wearable sensor platform bridges the gap between periodic hospital visits and home-based patient safety monitoring. Engineered specifically for complex oncology protocols, our screenless, medical-grade smart bracelets continuously gather high-fidelity vital parameters—including single-lead ECG, multi-wavelength PPG (green, red, infrared), continuous skin temperature, galvanometric skin response (GSR), and 3-axis movement actigraphy.
Information Gain Key Insight: By replacing episodic spot-checks with 128 Hz continuous signal acquisition, clinical trial sponsors operating in Hungary can identify early drug-induced cardiotoxicity (such as QTc prolongation or subclinical atrial fibrillation) up to 72 hours before overt clinical onset.
Localized Oncology Application Scenarios in Hungary
Tailored monitoring workflows designed to meet the rigorous operational standards of Hungary's premier academic research centers, oncology institutes, and contract research organizations (CROs).
Cardiotoxicity & QTc Monitoring
Targeted anti-cancer therapies (e.g., tyrosine kinase inhibitors, HER2-targeted agents) carry inherent risks of cardiac dysfunction and drug-induced QT prolongation. Deployed in clinical centers such as the National Institute of Oncology (Országos Onkológiai Intézet) in Budapest, our wrist-worn sensors capture continuous ECG rhythm strips and pulse wave velocity, enabling real-time detection of ventricular arrhythmias, early-stage atrial fibrillation, and autonomic imbalance without requiring burdensome 12-lead Holter setups.
Febrile Neutropenia Early Warning
Chemotherapy-induced severe neutropenia exposes cancer patients to swift systemic infection and septic shock. In decentralised studies managed across Semmelweis University Clinical Research Center and regional university hospitals in Debrecen, Szeged, and Pécs, our continuous micro-calorimetric skin temperature sensors register micro-transients in core thermal regulation. Automated alerts notify investigators of incipient febrile neutropenia before temperatures breach standard hospital triage thresholds.
Objective ECOG Functional Tracking
Subjective Eastern Cooperative Oncology Group (ECOG) performance status grading often suffers from inter-observer variability. Our 3-axis actigraphy algorithms translate patient motion, circadian rest-activity cycles, and gait kinematics into objective continuous digital biomarkers. Hungarian trial sites leverage this unbiased metrics baseline to quantify treatment efficacy, disease progression, and cancer-related fatigue (CRF) throughout Phase I-IV trials.
Hungarian Clinical Trial Landscape & Compliance Ecosystem
Hungary represents one of Central and Eastern Europe's most vibrant clinical trial hubs, offering exceptional medical infrastructure, highly qualified clinical investigator networks, and streamlined recruitment capabilities. However, integrating decentralized clinical trial (DCT) components into Hungarian trial sites requires strict adherence to both EU-wide mandates and national regulatory frameworks.
Regulatory Harmonization: OGYÉI, NNSZ, and EU CTR 536/2014
All medical device wearables deployed within clinical trials in Hungary must comply with the European Union Clinical Trials Regulation (EU CTR No 536/2014) and local oversight by the National Center for Public Health and Pharmacy (NNSZ)—formerly operating under the National Institute of Pharmacy and Nutrition (OGYÉI). Our hardware and cloud architecture are built strictly within ISO 13485 quality management systems, holding valid CE-MDR (EU Medical Device Regulation 2017/745) certification issued by European notified bodies such as Kiwa.
Data Sovereignty & EESZT Integration Readiness
Data privacy is paramount when conducting medical studies in Hungary. Under the General Data Protection Regulation (GDPR Article 9) and Hungarian health data legislation, patient-generated health data (PGHD) must be processed with end-to-end encryption and stored on sovereign European cloud infrastructure. Furthermore, our enterprise platform features API and SDK frameworks designed to seamlessly interface with hospital Electronic Medical Record (EMR) systems and the national National eHealth Infrastructure (EESZT - Elektronikus Egészségügyi Szolgáltatási Tér), ensuring seamless integration between clinical research pipelines and institutional care records.
| Evaluation Parameter | Consumer Fitness Trackers | Standard Clinical Holters | Our Oncology Wearable Platform |
|---|---|---|---|
| Regulatory Approval | General Wellness Only | Class IIa / Class IIb Medical | CE-MDR Certified & FDA 510(k) Cleared |
| Raw Data Access | Locked / Proprietary Averaging | Raw ECG Only (No PPG/Temp) | Unrestricted Raw PPG, ECG, Temp, GSR (128Hz) |
| Patient Wear Compliance | Variable (Consumer Apps) | Poor (Bulky Wires, Adhesive Rash) | High (>95% Compliance, Screenless Design) |
| Clinical Integration | None / Consumer Cloud | Manual USB Offload at Site | Automated REST APIs / Mobile SDK / EMR Sync |
| Telemetry Options | Bluetooth Only | Memory Card / Offline | BLE 5.2 Gateway & Standalone 4G LTE-M |
Factory Manufacturing Excellence & OEM/ODM Direct Capabilities
As a direct medical device manufacturing factory, we provide end-to-end B2B customization for global pharmaceutical sponsors, contract research organizations (CROs), and medical device distributors operating in the Hungarian market. Operating out of state-of-the-art, ISO 13485-certified facilities with Class 100,000 cleanroom manufacturing lines, we guarantee complete supply chain transparency and rigorous quality controls.
- Hardware Customization: Custom casing branding, specialized anti-microbial hypoallergenic wristband materials, and screenless configurations engineered to maximize trial compliance.
- Firmware & Algorithm Engineering: Protocol-specific sampling frequency adjustments, low-power continuous processing, and custom digital biomarker calculation (e.g., HRV, Pulse Arrival Time, QTc approximation).
- White-Label App & Cloud Infrastructure: Custom-branded iOS/Android gateway applications, localized into Hungarian, paired with study management portals and compliant data pipelines.
- IP-Free Raw Signal Export: Complete ownership of collected biometric signals without vendor lock-in, enabling sponsor data science teams to train proprietary machine learning models.
Frequently Asked Questions for Hungarian Clinical Trial Procurement
Expert answers addressing the technical, regulatory, and operational considerations of procurement managers, Principal Investigators (PIs), and trial logistics coordinators in Hungary.
Our wearable sensors and cloud platform hold valid CE-MDR certification under EU Medical Device Regulation (2017/745), audited by notified body Kiwa, alongside FDA 510(k) clearances. Manufacturing is fully certified under ISO 13485 quality standards. This regulatory status ensures that trial data collected across Hungarian site locations (e.g., Semmelweis, National Institute of Oncology) is fully admissible for regulatory submission to the EMA, FDA, and local NNSZ ethics committees.
Yes. Unlike consumer wearables that only output proprietary processed averages, our factory platform provides open, IP-free access to raw waveform data. You can export high-resolution raw accelerometer, multi-wavelength PPG (green, red, infrared), single-lead ECG rhythm strips, skin temperature, and GSR signals sampled at up to 128 Hz via our secure REST APIs, mobile SDKs, or raw CSV/JSON study exports.
All data architectures comply strictly with GDPR Article 9 requirements for special category health data. Biometric data is completely pseudonymized at the point of capture on the mobile gateway application. Patient-identifying information never touches the wearable hardware or cloud telemetry pipelines. Cloud infrastructure is hosted within sovereign EU data centers equipped with end-to-end AES-256 encryption at rest and TLS 1.3 in transit.
For standard pilot studies and investigator-initiated trials (IITs), off-the-shelf certified devices can be dispatched to Hungarian trial sites within 5 to 7 business days. Custom ODM/OEM production runs—featuring white-label app branding, tailored packaging, or protocol-specific firmware—typically carry an MOQ of 100 to 500 units with production lead times between 3 and 6 weeks.
Screenless smart bracelets eliminate patient confusion, accidental button presses, and anxiety caused by continuous vital sign displays. In oncology cohorts—where elderly patients or those experiencing severe fatigue may struggle with complex interfaces—our zero-touch screenless bands operate passively in the background, offering multi-week battery life and seamless automatic sync via bedside hub gateways or 4G cellular relays.
We provide full clinical support packages including site initiation training for investigators and research nurses, localized Hungarian-language patient instruction manuals, dedicated API integration engineers, and pre-configured device packaging ready for direct distribution to clinical trial logistics hubs in Budapest or regional site hospitals.
Empower Your Oncology Trial in Hungary With Medical-Grade Telemetry
Contact our clinical trial engineering specialists today to discuss trial protocol requirements, request technical documentation, or order evaluation kits for your upcoming study.
Get a Quote